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The innate immune system is ancient and highly conserved. It is the first line of defense and the only recognizable
immune system in the vast majority of metazoans. Signaling events that convert pathogen detection into a defense
response are central to innate immunity. Drosophila has emerged as an invaluable model organism for studying this
regulation. Activation of the NF-jB family member Relish by the caspase-8 homolog Dredd is a central, but still poorly
understood, signaling module in the response to gram-negative bacteria. To identify the genes contributing to this
regulation, we produced double-stranded RNAs corresponding to the conserved genes in the Drosophila genome and
used this resource in genome-wide RNA interference screens. We identified numerous inhibitors and activators of
immune reporters in a cell culture model. Epistatic interactions and phenotypes defined a hierarchy of gene action and
demonstrated that the conserved gene sickie is required for activation of Relish. We also showed that a second gene,
defense repressor 1, encodes a product with characteristics of an inhibitor of apoptosis protein that inhibits the Dredd
caspase to maintain quiescence of the signaling pathway. Molecular analysis revealed that Defense repressor 1 is
upregulated by Dredd in a feedback loop. We propose that interruption of this feedback loop contributes to signal
transduction.
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Introduction
As a typical metazoan suffers numerous microbial assaults
during its lifespan, survival depends on robust defense
strategies. Metazoan defenses are classiﬁed as either innate
or adaptive. Adaptive immunity is characterized by elaborate
genetic rearrangements and clonal selection events that
produce an extraordinary diversity of antibodies and T-cell
receptors that recognize invaders as nonself. While of
profound importance, the adaptive responses are slow and
limited to higher vertebrates. In contrast, the machinery of
innate immunity is germ-line encoded and includes phyloge-
netically conserved signaling modules that rapidly detect and
destroy invading pathogens (Medzhitov and Janeway 2000;
Janeway and Medzhitov 2002). Model organisms, particularly
insects, have played an important role in uncovering the
wiring of innate immune pathways (Hoffmann 2003). Im-
portantly, these organisms have provided powerful genetic
approaches for identifying molecules that sense pathogens,
elucidating steps that trigger innate defenses, and uncovering
the weaponry used to kill or divert potential pathogens
(Hoffmann et al. 1999). We have further reﬁned the
experimental approaches for rapid functional dissection of
immune responses and describe new steps in an important
pathway of the innate immune response.
Signaling in innate immunity consists of three steps:
detection of pathogens, activation of signal transduction
pathways, and mounting of appropriate defenses. The ﬁrst
step is triggered by the detection of pathogen-associated
molecular patterns by host pattern recognition receptors
(Akira et al. 2001). Typical pathogen-associated molecular
patterns are b-1,3-glucan of fungi, peptidoglycan and lipo-
polysaccharides (LPS) of bacteria, and phosphoglycan of
parasites. Signaling engages several pathways, including Toll,
tumor necrosis factor, mitogen-activated protein kinase
(MAPK), and Jun kinase pathways. NF-jB–type transcription
factors form an important downstream nexus of the signaling
pathways, and their activation promotes important defense
responses. Although the defense responses are diverse and
often tailored to the type of pathogen, some of the defense
strategies, such as production of a panel of antimicrobial
peptides, activation of phagocytic cells, and production of
toxic metabolites, are evolutionarily conserved.
Interest in Drosophila as a model for analyzing innate
immune signal transduction had a serendipitous origin. The
Toll signaling pathway was discovered and characterized in
Drosophila because of its role in speciﬁcation of the embryonic
dorsal ventral axis (Anderson et al. 1985). Similarities of
pathway components to genes involved in mammalian
immunity stimulated a hallmark study showing that the Toll
pathway is a central mediator of antifungal and gram-positive
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Open access, freely available online PLoS BIOLOGYbacterial defenses in Drosophila (Ip et al. 1993; Lemaitre et al.
1996). It is now recognized that Toll signaling is a conserved
mediator of innate immune responses. A combination of
classical genetics and molecular approaches has since
identiﬁed numerous components of Toll signaling in Dro-
sophila immunity, and it has highlighted similarities to
mammals at the level of signal transduction and differences
at the stage of pathogen detection (Ip et al. 1993; Rosetto et
al. 1995; Nicolas et al. 1998; Drier et al. 1999; Manfruelli et al.
1999; Meng et al. 1999; Rutschmann et al. 2000a, 2002; Tauszig
et al. 2000; Horng and Medzhitov 2001; Michel et al. 2001; De
Gregorio et al. 2002; Ligoxygakis et al. 2002; Tauszig-
Delamasure et al. 2002; Gobert et al. 2003; Weber et al. 2003).
A second pathway, the Immune deﬁciency (Imd) pathway,
mediates responses to gram-negative bacterial infection in
Drosophila (Lemaitre et al. 1995). Although similar to the
mammalian tumor necrosis factor pathway, there are several
differences between the two signaling cassettes, particularly
at the level of activation. As it is presently understood, the
Imd pathway is headed by an apparent pattern recognition
receptor, the transmembrane peptidoglycan recognition
protein LC (PGRP-LC; Choe et al. 2002; Gottar et al. 2002;
Ramet et al. 2002). Although the mechanisms are largely
unknown, signaling proceeds through Imd (homolog of
mammalian receptor interacting protein), dTAK1 (MAP3K
homolog), and a complex of Ird5/Kenny (homologous to the
IKKb/IKKc kinase). The active IKK complex phosphorylates
the p105 homolog Relish, and Dredd (caspase-8 homolog)
cleaves Relish, separating an N-terminal NF-jB domain of
Relish from a C-terminal ankyrin domain (Lemaitre et al.
1995; Dushay et al. 1996; Wu and Anderson 1998; Hedengren
et al. 1999; Hu and Yang 2000; Leulier et al. 2000, 2002;
Rutschmann et al. 2000b; Silverman et al. 2000; Stoven et al.
2000; Georgel et al. 2001; Lu et al. 2001; Vidal et al. 2001; De
Gregorio et al. 2002; Gottar et al. 2002; Khush et al. 2002;
Naitza et al. 2002; Silverman et al. 2003; Stoven et al. 2003;
Ryu et al. 2004). The N-terminal domain enters the nucleus
and promotes transcription of genes encoding proteins with
defense functions such as the antimicrobial peptide Dipter-
icin (Dipt), whose expression provides a signature for
activation of the pathway.
Unlike the Toll pathway, which was thoroughly studied in
its developmental capacities, analysis of the Imd pathway is
relatively recent. Its more complete genetic dissection may
well deﬁne another conserved and fundamental pathway of
immune signaling. Of particular interest, a pivotal step in the
Imd pathway—the regulation of Dredd-mediated cleavage of
Relish—is not understood. To begin to address this, we
developed a powerful RNA interference (RNAi)–based
approach to functionally dissect the Imd pathway. In
collaboration with others at the University of California,
San Francisco, we produced a library of 7,216 double-
stranded RNAs (dsRNAs) representing most of the phyloge-
netically conserved genes of Drosophila. We developed a cell
culture assay that allowed application of this library to a high-
throughput RNAi evaluation of Imd pathway activity. This
screen identiﬁed numerous components of signal trans-
duction (including negative and positive regulators of innate
immune signaling), deﬁned a hierarchy of gene action, and
identiﬁed a novel gene, sickie (sick), required for activation of
Relish. Focusing on regulation of the Dredd caspase, we
identiﬁed a novel inhibitor of Dredd, Defense repressor 1
(Dnr1), which is upregulated by Dredd in a feedback loop that
maintains quiescence. We propose that interruption of this
feedback loop contributes to signal transduction.
Results
A Drosophila Reporter Cell Line of Imd Pathway Activity
To facilitate rapid dissection of Imd pathway signaling, we
established an S2 reporter cell line that expresses b-
galactosidase under control of the promoter from a gene,
Dipt, that encodes an antimicrobial peptide, Dipt-lacZ.
Commercial preparations of LPS contain bacterial cell wall
material capable of activating the receptor PGRP-LC and act
as gratuitous inducers of antimicrobial peptide genes in
Drosophila tissue culture cells (Samakovlis et al. 1992;
Engstrom et al. 1993; Dimarcq et al. 1997). Consistent with
previous studies, 20-hydroxyecdysone enhanced Dipt-lacZ
induction by LPS (Figure 1A; Silverman et al. 2000, 2003).
Inactivation of critical Imd pathway members (PGRP-LC,
Imd, Ird5, and Dredd) by RNAi virtually eliminated Dipt-lacZ
induction by LPS (Figure 1B). In contrast, inactivation of the
Toll pathway members Spaetzle, Tube, or Dif by RNAi had no
effect on LPS-dependent induction of Dipt-lacZ. We con-
clude that LPS-dependent induction of Dipt-lacZ requires an
intact Imd signaling pathway.
To identify additional modulators of Dipt-lacZ expression,
we prepared a library of 7,216 dsRNAs representing most of
the phylogenetically conserved genes of Drosophila. Using the
Dipt-lacZ cell line, we performed a high-throughput RNAi
screen for genes whose inactivation impinges on Dipt-lacZ
induction. In one screen, we identiﬁed dsRNAs that altered
Dipt-lacZ induction by LPS, either enhancing or suppressing
activation. In a second screen performed without addition of
LPS, we identiﬁed genes whose inactivation spontaneously
activated the reporter. The phenotypes deﬁned three
categories of genes, which we named—based on the pheno-
type of their inactivation—decreased defense by RNAi (DDRi)
genes, enhanced defense by RNAi (EDRi) genes, and
constitutive defense by RNAi (CDRi) genes (Figure 1).
Identification of DDRi, EDRi, and CDRi Genes
In an initial visual screen, dsRNAs that altered the induced
or constitutive expression of b-galactosidase were selected as
candidate innate immunity genes. We subjected all the initial
positives to a more stringent retest where we resynthesized
the candidate dsRNAs, retested these under identical
conditions, and counted the number of b-galactosidase-
positive cells. We deﬁned DDRi dsRNAs as reducing the
frequency of Dipt-lacZ-expressing cells to below 40% of LPS-
treated controls, EDRi dsRNAs as increasing the frequency of
Dipt-lacZ-expressing cells more than 2-fold, and CDRi
dsRNAs as inducing Dipt-lacZ-expressing cells to a level
equal to or higher than that induced by LPS. About 50% of
the initial positives met these criteria, yielding 49 DDRi
dsRNAs, 46 EDRi dsRNAs, and 26 CDRi dsRNAs (Figure 2A–
2C; Table 1). The entire process of screening and retesting
was performed without knowing the identity of the dsRNAs.
Nonetheless, we successfully identiﬁed all of the known Imd
pathway components in the library (PGRP-LC, Dredd, and
Relish) as DDRi genes, supporting the validity of this
approach for identifying genes that affect Imd pathway
signaling.
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RNAi Screen of Innate ImmunityThe dsRNAs that enhance, and those that constitutively
activate, the immune reporter are both expected to target
inhibitors of the immune response. Nonetheless, there was
only a small overlap between the EDRi genes and CDRi genes.
Of the 46 conﬁrmed EDRi dsRNAs, only ﬁve caused a CDRi
phenotype, suggesting that the mechanisms that silence Imd
pathway activity in the absence of infection are largely
distinct from those moderating or downregulating the
response to infection. We distinguish the ﬁve EDRi genes
capable of constitutive activation and designate them EDRi
C.
EDRi
C genes are listed as both EDRi and CDRi (Figure 2B and
2C, indicated with an asterisk). Approximately half of the
CDRi dsRNAs also caused morphological defects (Figure 2C,
indicated with a pound sign), i.e., enlarged cells with irregular
cytoskeletal structures (see Figure 1J). While we do not know
the basis for the altered morphology, gene expression
Figure 1. A Cell Culture Screen Identifies Novel Regulators of the Innate Immune Response
(A) LPS induces an increase of about 10-fold in the number of Dipt-lacZ cells that stain positively for b-galactosidase. Ecdysone sensitizes the
cells and promotes the response.
(B) Dipt-lacZ induction by LPS requires known Imd signaling components, but not Tl pathway members. The fraction of b-galactosidase-positive
cells was normalized to the induced control (normalized %), and inﬂuence of RNAi of Tl pathway members (dif, spz, and tub) or Imd pathway
members (PGRP-LC, Imd, Ird5, and Dredd) is shown.
(C–H) Activity stain (X-Gal) for b-galactosidase.
(C) Untreated cells.
(D) Cells treated with ecdysone alone.
(E) Cells treated with ecdysone and LPS. About 10% of cells express detectable b-galactosidase.
(F) RNAi against the DDRi sick reduces Dipt-lacZ expression in response to LPS.
(G) RNAi of a representative EDRi, the Ras signaling pathway component Cnk, enhances Dipt-lacZ induction by LPS.
(H) RNAi of a representative CDRi, the actin regulator SCAR induces Dipt-lacZ in the absence of LPS.
(I–J) Immunoﬂuorescence of S2 cells with actin in red, tubulin in green, and DNA in blue. Scale bars in (I) and (J) indicate 10 lm.
(I) Wild-type cells have a characteristic rounded morphology.
(J) RNAi against many CDRi genes disrupts morphological features of wild-type S2 cells. S2 cells are shown treated with MESR4 dsRNA. Cells are
signiﬁcantly larger in appearance and less round, with irregular tubulin and actin networks.
DOI: 10.1371/journal.pbi0.0020203.g001
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RNAi Screen of Innate Immunityproﬁling showed that LPS induces numerous cytoskeletal
regulators, suggesting that cytoskeletal rearrangement is a
component of the innate immune response (Boutros et al.
2002).
We also observed EDRi and CDRi phenotypes upon
inactivation of Act5C and Act42A. Due to extensive sequence
homology, RNAi against either actin triggers destruction of
both transcripts (A. Echard, G. R. X. Hickson, E. Foley, and P.
H. O’Farrell, unpublished data). Inactivation of either actin
with dsRNA directed to the actin UTRs demonstrated that
both actin transcripts must be inactivated for an observable
EDRi or CDRi phenotype (Figure 2B and 2C).
Epistatic Evaluation of CDRi Genes
As RNAi of CDRi genes leads to ectopic Dipt-lacZ
induction, we reasoned that CDRi genes are required to
maintain quiescence in the absence of LPS and that induction
by a CDRi dsRNA corresponds to release of inhibition of the
Imd pathway. The large number of CDRi genes makes it likely
that individual CDRi genes inhibit distinct steps in the Imd
pathway. We sought to determine the position at which the
individual CDRi genes impact the Imd pathway. In contrast to
Caenorhabditis elegans, several genes can be inactivated by RNAi
in Drosophila without an obvious drop in the efﬁciency of gene
inactivation (Li et al. 2002; Schmid et al. 2002). The ability to
inactivate two different gene products in sequence by RNAi
provides a powerful tool to position CDRi genes relative to
known Imd pathway components. In a ﬁrst step, we
inactivated one of three known Imd signaling compo-
nents—either Imd, Dredd, or Relish. In a second step, we
inactivated individual CDRi genes and monitored Dipt-lacZ
induction. We reasoned that inactivation of Imd, Dredd, or
Relish would not block pathway derepression by a CDRi
dsRNA if the cognate CDRi impinged on the pathway at a
step beyond the actions of Imd, Dredd, or Relish. Using this
approach, we subdivided 20 CDRi genes into ﬁve epistatic
groups (Figure 2C; Table 2). Group I contained four CDRi
dsRNAs whose action was independent of Imd, Dredd, and
Relish. Group II contained 12 dsRNAs whose CDRi pheno-
type was independent of Imd and Dredd, but depended on
Relish. Group III contained two dsRNAs whose CDRi
phenotype was Dredd-independent, but was reduced in the
absence of Imd and Relish. Group IV contained a single
dsRNA whose phenotype was independent of Imd, but
dependent on Dredd and Relish. Finally, Group V contained
three dsRNAs whose ability to activate the immune reporter
depended on Imd, Dredd, and Relish. The epistatic relation-
ships demonstrate that genes in Groups II–V have inputs into
the known Imd pathway, while Group I might have inputs in
independent pathways required for effective Dipt-lacZ
expression.
Sick Is a Conserved Gene Required for Relish Activation
We are particularly interested in regulators contributing to
activation of the Relish transcription factor by the caspase
Dredd, because this is such a pivotal step in the Imd pathway
and its regulation is not understood. To identify regulators
that affect Relish processing, we developed an assay that more
directly monitored Relish activation. We produced an S2 cell
line that expresses a copper-inducible N-terminal green
ﬂuorescent protein (GFP)–tagged Relish (GFP-Relish; Figure
3). GFP-Relish is predominantly cytoplasmic in untreated
cells (Figure 3A) and rapidly translocates to the nucleus upon
treatment of cells with LPS or exposure to Escherichia coli
(Figure 3B and 3D). Western blot analysis with a monoclonal
anti-GFP antibody showed that GFP-Relish is rapidly pro-
cessed from a full-length form to a shorter form after
exposure to LPS (Figure 3C). These ﬁndings indicate that the
Figure 2. List of Modulators of the Immune Response and a False Color
Display of Their Influence on Dipt-lacZ Induction
The genes identiﬁed as DDRi (A), EDRi (B), and CDRi (C) are listed,
and the colored bars show the inﬂuence of the corresponding dsRNA
on Dipt-lacZ expression. The top two entries in (A), (B), and (C) show
control cells (no dsRNA) without and with LPS, respectively. The
scales for the false colors are given at the bottom left. Dipt-lacZ levels
are given in terms of percent positive cells. For exact Dipt-lacZ
expression values for each dsRNA refer to accompanying supple-
mental tables. In (B), the color scale (right) is compressed and
extended compared to (A), and an asterisk indicates genes that also
caused a CDRi phenotype. In (C), the pound sign indicates
morphological defects and an asterisk indicates genes that also
caused an EDRi phenotype, and the division of the genes into
epistatic groups is shown. To the immediate left a false-color bar
(coded as in [B]) indicates the effect of the dsRNAs on Dipt-lacZ
expression without LPS addition. The block of colored columns
shows the results of epistasis tests. Here, we set the undisturbed level
of CDRi activation to 100% (as indicated in the left column in this
group and the color code below), and to the right we represent
reduction of this activation by prior RNAi of different Imd pathway
genes. Five epistatic clusters (I–V) were identiﬁed (indicated by the
lines to the left).
DOI: 10.1371/journal.pbi0.0020203.g002
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RNAi Screen of Innate ImmunityTable 1. Measurement of the Percent of LacZ-Positive Cells After Treatment with dsRNA Against Individual EDRi, DDRi, and CDRi Genes
Gene
Category
Name Function CG Flybase Percent
LacZ-Positive
Cells
Control  LPS 2
þLPS 10
DDRi Cct1 1049 Choline-phosphate cytidylyltransferase. 4
mRpS2 Mitochondrial ribosomal protein 2937 3
Yp2 Structural protein 2979 Yolk protein. Similarity to vitellogenin.
Lipase domain.
3
CG2656 Purine nucleotide binding 2656 P-loop containing nucleotide triphos-
phate hydrolase.
4
CG4408 4408 Metalocarboxypeptidase. 4
PGRP-LC Peptidoglycan recognition protein 4432 Peptidoglycan recognition activity. Im-
mune response. Integral to mem-
brane.
3
CG4459 Transporter 4459 Organic cation porter. 3
CG5146 5146 Cell communication. Signal transduc-
tion.
3
Trap95 TF 5465 3
ppan 5786 Required for larval growth. 3
CG5844 Enzyme 5844 Dodecenoyl CoA delta-isomerase activ-
ity.
2
ATPsyn-d ATP synthase 6030 ATP synthase subunit d. 4
RpL22 Translation 7434 Ribosomal protein. 3
Dredd Apoptosis/immunity 7486 Caspase. Apoptotic program. Defense
response.
3
CG7702 7702 Cell adhesion. Transmission of nerve
impulse. RNI-like.
3
CG8129 Threonine dehydratase 8129 Threonine ammonia lyase activity. 1
Sox15 DNA binding 8404 DNA bending. Transcription factor. 2
Asph 8421 Peptide aspartate beta dioxygenase. 2
CG8506 8506 Zinc finger. 4
CG8494 Endopeptidase 8494 Ubiquitin protease involved in deubiq-
uitination.
3
CG32374 Endopeptidase 32374 Trypsin activity; serine-type endopepti-
dase activity. Proteolysis and peptido-
lysis.
3
CG8786 8786 Intracellular protein transport. Protein-
peroxisome targeting. RING finger do-
main. WWE domain.
3
Aats-arg Protein synthesis 9020 Arginine tRNA ligase. 3
Ots48 9022 Oligosaccharyltransferase. N-linked gly-
cosylation
4
CG9121 Cytoskeleton 9121 Structural constituent of cytoskeleton.
Cytoskeletal anchoring. Ankyrin repeat.
4




Tulp 9398 Transcription factor tubby, C-terminal
domain.
2
CG9531 9531 Protoporphyrinogen oxidase activity.
SAM binding motif.
4
CG9809 RNA binding 9809 RNA binding 3
EIF-2a Protein synthesis 9946 GTP binding. tRNA binding translation
initiation factor activity. Translational
initiation.
1
CG10226 Transporter 10226 Multidrug transporter ABC transporter 3
PLoS Biology | www.plosbiology.org August 2004 | Volume 2 | Issue 8 | e203 1095
RNAi Screen of Innate ImmunityTable 1. Continued.
Gene
Category
Name Function CG Flybase Percent
LacZ-Positive
Cells
CG10418 RNA binding 10418 Pre-mRNA splicing factor activity. Nu-
clear mRNA splicing, via spliceosome.
2
CG10423 Protein synthesis 10423 Structural constituent of ribosome 2
Dox-A2 Endopeptidase 10484 Endopeptidase activity. Proteolysis and
peptidolysis.
4
CG10662 10662 Nucleotide triphosphatase hydrolase 4
Aats-asn Protein synthesis 10687 Asparagine-tRNA ligase activity. Aspar-
aginyl-tRNA aminoacylation.
3
Slo 10693 Calcium-activated potassium channel
activity.
3
cIF2 Protein synthesis 10840 Translation initiation factor activity.
DEAD/H-box RNA helicase binding.
Translational initiation.
2
CG10881 Translation factor 10881 RNA binding. Translation initiation fac-
tor activity. Translational initiation.
4
CG11201 11201 Glutathione synthetase ATP-binding
domain-like.
3
Ubiquitin 11700 DNA metabolism. DNA repair. Ubiqui-
tin-like.
4
EF1c Translation factor 11901 Translation elongation factor activity.
Translational elongation. EF1c.
3
CG11990 11990 Cell communication. Signal transduc-
tion.
4
Relish Imd pathway 11992 Transcription factor activity. Antibac-
terial polypeptide induction, antifungal
polypeptide induction.
2
CG12512 12512 Long-chain fatty acid CoA ligase. 3




RpL27A Protein synthesis 15442 Structural constituent of ribosome.
Protein biosynthesis.
2
CG15636 DNA binding 15636 Chromo domain. 3
CG30079 30079 Exocytosis; intracellular protein trans-
port.
4
EDRi Klp10A Motor protein 1453 Kinesin motor activity. Microtubule-
based movement.
42




CG2926 TF 2926 31
CG3542 3542 FH1-domain binding. Nuclear mRNA
splicing, via spliceosome.
38
CG4119 4119 RNA binding. 28
CG4448 Signal transduction 4448 Microtubule severing. 28
Actin Cytoskeletal structural protein Actin cytoskeleton. 22
MESR4 TF 4903 Interacts with ras85D. 21
Pi3K59F Pi3kinase 59F 5373 Phosphatidylinositol 3-kinase activity.
Phosphoinositide phosphorylation.
34
B-H2 TF 5488 DNA binding. Transcription factor ac-
tivity.
26
CG6514 Calcium binding 6514 Calcium ion binding. 19
cnk Signal transduction 6556 PDZ domain. Interacts with Ras. 37
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RNAi Screen of Innate ImmunityTable 1. Continued.
Gene
Category
Name Function CG Flybase Percent
LacZ-Positive
Cells
ial 6620 Protein serine/threonine kinase activ-
ity. Cytokinesis; establishment and/or
maintenance of chromatin architec-




Med21 Transcription 6884 Regulation of transcription from PolII
promoter.
21
CG7349 Enzyme 7349 Succinate dehydrogenase activity. 19
eff Ubiquitin conjugating 7425 Ubiquitin conjugating enzyme activity. 24
AG02 7439 Translation initiation factor activity;
protein binding; RNAi; translational ini-
tiation.
27
CG7564 7564 MRNA binding. SnRNP complex. 20
CG7597 7597 Cyclin-dependent kinase activity. RNA
polymerase subunit kinase activity.
21
CG7633 7633 Integral to membrane. 25
CG7708 7708 Proline:sodium symporter activity. 20
CG8285 Chaperone 8285 Chaperonin ATPase activity. GroEL-like. 20
SelD 8553 NOT selenide, water dikinase activity;
cell proliferation.
21
Rac2 8556 Cytoskeleton rearrangements. 20
Cirl G-protein-coupled receptor 8639 Latrotoxin receptor activity; G-protein
coupled receptor protein signaling
pathway.
33
CycD Cell cycle regulator 9096 Cyclin-dependent protein kinase, in-
trinsic regulator activity; cell prolifera-
tion.
26
Ac13E 9210 Adenylate cyclase activity. 20
CG9267 9267 Protein complex assembly; protein
folding; protein metabolism.
26
CG9346 RNA binding 9346 RNA binding. 24
flfl Signal transduction (Rac) 9351 RAC protein signal transduction. 24
Ras85D Signal transduction 9375 RAS small monomeric GTPase activity. 22
CG9469 9469 21
CG9646 9646 SAM methyl transferase. 30
CG31187 DAG kinase 9857 Diacylglycerol kinase activity; diacyl-
glycerol binding. Phosphorylation.
19
U2af50 RNA binding 9998 premRNA splicing factor activity; poly-
pyrimidine tract binding; nuclear
mRNA splicing, via spliceosome; splice-
osome complex.
22
CG11799 TF 11799 Transcription factor activity. Forkhead
domain.
22
pUf68 RNA binding 12085 Poly(U) binding; premRNA splicing fac-
tor activity. Nuclear mRNA splicing, via
spliceosome.
30
CG12113 12113 Cell communication; intracellular pro-
tein transport; protein targeting; signal
transduction.
23
kek5 Cell adhesion 12199 MHC domain. Ig C-2 type domain.
Outer arm dynein light chain.
22
Arc92 12254 RNA polII transcription mediator activ-
ity.
21
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RNAi Screen of Innate ImmunityGFP-Relish cell line is a reliable reporter for Relish
activation. Additionally, inactivation of PGRP-LC by RNAi
prevented nuclear translocation of GFP-Relish in response to
bacterial exposure (Figure 3E), indicating that the reporter
can be used to assay function of Imd pathway genes.
We tested all DDRi dsRNAs for their effects on the
response of GFP-Relish to LPS (Figure 3F). Most DDRi
dsRNAs did not affect GFP-Relish levels or its LPS-stimulated
nuclear concentration, suggesting that their effects on Dipt-




Name Function CG Flybase Percent
LacZ-Positive
Cells
CG14641 RNA binding 14641 Zinc finger. RNA binding domain. 27
1 (2)44Db 14750
ena 15112 Actin binding. PH domain. Abl interac-
tor.
23
CG15365 15365 Cell cycle. Mitosis. 23
CG18176 18176 ARM repeat. 20
ph-p TF 18414 DNA binding. Gene silencing. 25
CDRi CG1102 Endopeptidase 1102 Monophenol mono-oxygenase activa-
tor. Defense response.
9
CG1804 1804 IG/MHC domains. Leucine-rich repeat. 9
Plkk1 Kinase 4527 Receptor signaling protein S/T kinase. 8
SCAR Cytoskeleton regulation 4636 Actin binding. WASP/SCAR family. 9
MESR4 Interacts with Ras signaling 4903 Interacts with Ras. Zn finger. 10
CG5503 Signal transduction 5503 Guanyl nucleotide exchange factor.
Dbl domain (rho GEF). Two transcripts.
8
CG5793 5793 Fumarylacetoacetate hydrolase. 8
Bx Transcription 6500 Wing morphogenesis, germ-line devel-
opment.
11
CG32055 Insulin-like growth factor binding 32055 12
Nup170 6743 Nuclear pore. Homologue of rat NUP
107.
13
trp Voltage-gated Ca channel. 7875 Calcium channel. Ankyrin repeat. Eye
phenotype.
8
CG8211 8211 Highly conserved homologues in hu-
mans and mice (about 38% identity
over entire protein).
18
rhol Ras GTPase 8416 Cytoskeleton. 8
CG8426 8426 Transcription. 9
xmas-1 8919 RNA-binding domain. Embryonic de-
velopment.
13
FucTD 9169 Galactoside 3-1 fucosyltransferase. 11
CG9646 9646 SAM methyl transferase. 8
Actin Cytoskeletal structural protein Actin cytoskeleton. 12
CG12079 Respiratory chain 12079 11
pUf68 RNA binding 12085 MRNA splicing. 19
KCNQ KCNQ potassium channel 12215 Cation channel, nonligand gated. 9
dnr1 12489 FERM domain. RING finger domain. 10
CG13189 13189 Metal transporter domains. 10
CG14801 14800 Xonuclease domain. Four transcripts. 25
CG18176 18176 ARM repeat. 13
Eip93F Autophagy, apoptosis 18389 Apoptosis induced by hormones. Ec-
dysone responsive. DNA binding.
8
TF, transcription factor
Cell culture conditions were as described above, with the exception that CDRi genes were not treated with LPS. For each sample, 350–550 cells were counted. Controls
(þ LPS and  LPS) are the average of five independent experiments. EDRi genes were defined as having greater than or equal to twice þLPS control induction levels. DDRi
genes were defined as having less than or equal to 40% ofþLPS control induction levels. CDRi genes were defined as having greater than or equal to four times LPS control
levels. Results were reproducible for all genes subjected to further analysis.
DOI: 10.1371/journal.pbi0.0020203.t001
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RNAi Screen of Innate ImmunityDDRi dsRNAs (Relish, ubiquitin, CG8129, and Asph) severely
reduced GFP-Relish levels, indicating that these dsRNAs
directly or indirectly interfered with Relish expression or
stability. The ability of these dsRNAs to block Dipt-lacZ
induction suggests that Dipt-lacZ induction requires sub-
stantial levels of Relish. We identiﬁed four DDRi dsRNAs that
prevented LPS-stimulated nuclear translocation of GFP-
Relish: PGRP-LC, Dredd, Dox-A2, and CG10662. We named
CG10662 sick. While prolonged Dox-A2 RNAi caused cell
lethality, cell viability appeared unaffected by sick RNAi for
up to 8 d. As sick RNAi prevents nuclear translocation of GFP-
Relish and decreases Dipt-lacZ induction after LPS treat-
ment, we propose that the Imd pathway requires sick activity
for Relish-dependent Dipt-lacZ induction.
Epistasis provides a second approach for positioning a
DDRi gene in the hierarchy of gene action. To this end we
assessed the relationship of sick to the ﬁve CDRi epistatic
groups that we deﬁned (above). We inactivated sick by RNAi
and subsequently tested dsRNAs representing the ﬁve CDRi
epistatic subgroupings for their ability to activate Dipt-lacZ
expression in the absence of Sick (Figure 3G; Table 3). Group
I and II CDRi do not require Sick, indicating that Sick acts
upstream of, or in parallel to, their action, which is at the
level of Relish or downstream of Relish. Induction of Dipt-
lacZ by Group III and IV CDRi dsRNAs requires Sick,
suggesting that Sick is required for the effective induction
of Dipt-lacZ by Dredd and Imd. Combined with the observed
Sick requirement for Dipt-lacZ induction and the nuclear
translocation of Relish by LPS, these data imply that Sick
either mediates or supports Relish activation by Dredd and
Imd.
Dnr1 Is a Novel Inhibitor of Dredd
Negative regulators are likely to participate in the circuitry
that controls Dredd activation of Relish. The key candidate
for action at this level was the single Group IV CDRi gene,
CG12489, which showed epistatic relationships consistent
with a role in inhibiting Dredd. RNAi of CG12489 induced
Dipt-lacZ expression without immune stimulus, indicating
that CG12489 normally prevents Dipt expression. As
CG12489 inactivation fails to induce Dipt-lacZ in the absence
of Dredd or Relish (see Figure 2C), we reasoned that CG12489
normally suppresses Dredd-dependent induction of Dipt-
lacZ. We named this gene dnr1 and discuss its actions more
fully below.
Dnr1 is a conserved protein with an N-terminal ezrin/
radixin/moesin domain and a C-terminal RING ﬁnger (Figure
4A). To conﬁrm that Dnr1 inactivation stimulated Dipt-lacZ
production, we measured the b-galactosidase activity of
lysates from Dipt-lacZ cells treated with dnr1 dsRNA.
Exposure of Dipt-lacZ cells to LPS reproducibly increased
Dipt-lacZ production 4- to 5-fold (Figure 4B). Importantly, in
three independent experiments, Dnr1 RNAi stimulated Dipt-
lacZ production to a similar degree in the absence of LPS.
Furthermore, Dipt-lacZ activation in response to LPS was
Table 2. Measurement of the Percent of LacZ-Positive Cells after Treatment with dsRNA against Imd, Dredd, or Relish Followed by
RNAi for the Individual CDRi
Gene Name Epistatic Group RNAi RNAi with Imd RNAi RNAi with Dredd RNAi RNAi with Relish RNAi
CG1804 I 12.1 13.0 10.8 9.8
xmas-1 I 14.6 16.4 18.0 10.2
CG14801 I 14.6 14.9 14.6 9.3
Plkk1 I 8.0 7.1 6.0 9.0
SCAR II 11.4 10.1 11.8 4.1
CG5503 II 8.7 10.2 8.1 2.3
CG8211 II 16.0 20.9 17.9 2.9
Nup170 II 10.9 8.0 8.1 3.1
CG8426 II 11.0 9.4 10.3 3.3
fucTD II 15.4 14.4 16.0 1.8
CG9646 II 11.2 10.6 11.0 2.8
CG12079 II 10.3 11.7 14.1 2.8
pUf68 II 18.7 20.6 17.6 5.5
CG13189 II 9.1 9.0 7.6 1.4
CG18176 II 11.9 10.7 17.8 3.7
Actin II 9.0 7.1 8.3 2.6
CG1102 III 9.4 2.4 7.2 2.3
MESR4 III 10.9 6.4 8.8 4.7
dnr1 IV 10.1 10.1 3.5 3.1
CG5793 V 8.6 4.1 3.3 1.3
CG12215 V 10.7 4.8 3.6 0.9
Eip93F V 11 5 6.5 1.5
Cell culture conditions were as described in the body of the manuscript, with the exception that CDRi genes were not treated with LPS. For each sample, 350–550 cells were
counted.
DOI: 10.1371/journal.pbi0.0020203.t002
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RNAi Screen of Innate Immunityessentially reduced to background levels upon inactivation of
sick. These ﬁndings provide additional support for negative
and positive regulation of Relish by Dnr1 and Sick, respec-
tively. While we detected genes with similarity to dnr1 in many
higher eukaryotes, we failed to ﬁnd a homolog of Dnr1 in C.
elegans. Interestingly, C. elegans does not rely on an Imd
pathway for innate defenses (Kurz and Ewbank 2003). Other
RING ﬁnger proteins are E3 ubiquitin ligases that target a
variety of substrates for proteolytic destruction. The RING
ﬁnger motif in Dnr1 has greatest sequence homology to the
RING ﬁngers found in inhibitor of apoptosis proteins (IAPs;
Figure 4C). IAPs are critical inhibitors of caspase activity that
ubiquitinate their targets and promote autoubiquitination
(Bergmann et al. 2003). Previous reports demonstrated that
caspase inhibitors activate their own destruction and that this
activity is RING ﬁnger mediated (Yang et al. 2000). Consistent
with these reports, we observed surprisingly low levels of
accumulation of a hemagluttanin (HA)–tagged Dnr1 in
transfected cells. A point mutation in a residue critical for
RING ﬁnger function resulted in increased accumulation of
transfected HA-Dnr1 (Figure 4D). We also detected a protein
processing event that appears to depend on the RING ﬁnger.
Upon expression of C-terminally HA-tagged Dnr1, we
observed a slightly lower molecular weight isoform, suggesting
N-terminal processing of Dnr1 (Figure 4E). The absence of
this lower molecular weight isoform in cells transfected with
the N-terminally HA-tagged Dnr1 (Figure 4D) is consistent
with processing near the N-terminus. This processed isoform
was absent in cells transfected with constructs containing the
RING ﬁnger mutation (Figure 4E). The presence of the RING
ﬁnger motif, and its apparent role in destabilizing Dnr1,
argues that Dnr1 is a caspase inhibitor and that, given its
functional role and epistatic position as an inhibitor of
Dredd, it is likely to act directly to inhibit this caspase.
Dnr1 Protein Levels Are Regulated by Dredd Activity
While LPS had no dramatic effect on the subcellular
localization of HA-Dnr1 (Figure 4F and 4G), exposure to LPS
had a transient effect on the levels of Dnr1 protein. Addition
of LPS caused an increase in HA-Dnr1 levels (Figure 5A),
which rose 4- to 5-fold 2 h after treatment with LPS and then
gradually declined. Since LPS-dependent processing of Relish
by Dredd proceeded in a similar manner (see Figure 3C), we
tested whether Dredd inactivation affected Dnr1 protein
levels. Cotransfection of the caspase inhibitor p35 along with
HA-Dnr1 blocked HA-Dnr1 accumulation (Figure 5B).
Similarly, even transient treatment with the caspase inhibitor
z-VAD-FMK at concentrations sufﬁcient to prevent Relish
processing (Figure 5C) reduced LPS-dependent HA-Dnr1
accumulation (Figure 5D). As these data implicated caspase
function in Dnr1 accumulation, we tested the ﬁve Drosophila
caspases represented in our library for their inﬂuence on
Dnr1 stability. Only Dredd RNAi reproducibly reduced HA-
Dnr1 levels (Figure 5E and 5F). Consistent with a role for
Dredd as the critical caspase in LPS-dependent Relish
activation, of all caspases tested only Dredd inactivation
blocked LPS-dependent Dipt-lacZ induction (Figure 5G).
In summary, addition of LPS to S2 cells activates Dredd and
stabilizes Dnr1, while inactivation of Dredd by RNAi or
caspase inhibitors reduces Dnr1 protein levels. We conclude
that Dnr1 protein levels are regulated by Dredd activity.
While it is not presently known how Dredd caspase function
Figure 3. A GFP-Relish Reporter Cell Line Subdivides DDRi dsRNA into
Three Categories
(A–B) Immunoﬂuorescence of GFP-Relish cells with GFP-Relish in
green, DNA in blue, and actin in red. Relish is predominantly
cytoplasmic in untreated control cells and rapidly translocates to the
nucleus of cells incubated with LPS.
(C) An anti-GFP Western blot of lysates harvested from GFP-Relish
cells treated with LPS for different periods. GFP-Relish rapidly shifts
from a full-length form to a shorter processed form after exposure to
LPS, and full-length Relish gradually reaccumulates.
(D–E) Immunohistochemistry of GFP-Relish cells incubated with
GFP-expressing E. coli (arrowheads) and treated with (E) or without
(D) dsRNA against PGRP-LC. Imd pathway inactivation prevents
bacterial-induced Relish nuclear translocation.
(F) Shows effects of treatment of GFP-Relish cells with DDRi dsRNAs
for 4 d prior to LPS treatment. GFP-Relish was scored as cytoplasmic
(uninduced), nuclear (induced), or reduced in amount (abnormal).
(G) Shows an epistatic analysis of the DDRi, sick. Suppression of sick
interferes with Dipt-lacZ induction by Group III, IV, and V CDRi
dsRNAs, but not those of Groups I and II, suggesting that Sick acts
downstream of Imd and Dredd, but upstream of Relish in signal
transduction.
DOI: 10.1371/journal.pbi0.0020203.g003
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RNAi Screen of Innate Immunitymight inﬂuence Dnr1 accumulation, we note that the data are
consistent with a negative feedback loop in which Dredd
activity promotes accumulation of its own inhibitor, Dnr1.
Discussion
It was previously recognized that the Drosophila macro-
phage-like S2 cell line responds to bacterial cell wall
components with the induction of antimicrobial peptide
expression. This model lacks the complexities of communi-
cation between tissues that drive the spread of the immune
response in larvae (Foley and O’Farrell 2003), but it offers an
exceedingly powerful system for identiﬁcation of mediators
of antimicrobial peptide induction. To develop a genetic
approach to identify novel signal transduction components,
we produced reporter cell lines to follow innate immune
signaling and a library of 7,216 dsRNAs representing the
conserved genes of Drosophila to inactivate genes by RNAi. We
focused on a screen for immune response genes in the Imd
pathway because it is the less thoroughly understood of the
two immune response pathways in Drosophila. A central aspect
of our strategy for dissection of the pathway was to identify
negative regulators as well as positively acting genes. In
addition to modulating signal transduction pathways, neg-
ative regulators participate directly in signaling when down-
regulated by the inducing signal. Beyond the inherent
importance of this relatively unexplored group of regulators,
we were interested in their potential utility as an exper-
imental lever: Identiﬁcation of inhibitors acting at numerous
levels of the pathway provides tools for ordering the action of
the positively acting genes in the pathway and vice versa. The
experimental approach and strategy proved highly efﬁcient,
yielding numerous regulators and deﬁning a cascade of gene
action by epistasis. A secondary test for the inﬂuence of
positively acting genes on the nuclear translocation of Relish
and the epistasis order allowed us to narrow our focus to
genes that are centrally involved in the immune response.
Focusing on the unresolved issue of Dredd regulation, we
characterized a negative regulator, Dnr1, that provides a
critical check on unwarranted Dredd activity. Our results
suggest that Dredd controls Dnr1 stability in a negative
feedback loop that restricts Dredd function. Normal activa-
tion of the Imd pathway may include release or bypass of this
negative feedback loop.
Categories of Innate Immune Inhibitors
A priori, we considered two roles for inhibitors of the Imd
pathway: either suppression of spontaneous activation of
immune responses in the absence of infection, or down-
modulation of a response to limit or terminate it. We
designed screens for both these types of activities. In
conjunction with the RNAi screen for dsRNAs that blocked
response to LPS, we identiﬁed dsRNAs that enhanced the
response—EDRis. This phenotype represents a failure to
downmodulate the response. In an independent screen
without LPS, we identiﬁed dsRNAs that resulted in con-
stitutive activation of the pathway—CDRis. Surprisingly,
there was remarkably little overlap in the genes identiﬁed
in these two screens: Of 26 CDRis and 46 EDRis only ﬁve were
in common. At present, we do not understand the functional
underpinnings of the distinctions between inhibitors that
sustain quiescence (CDRis) and those that downregulate an
ongoing response (EDRis).
Interestingly, groups of inhibitors implicate distinct path-
ways in immune regulation. For example, of the 17 genes that
had the strongest EDRi phenotype, four encode splicing
factors and four encode products that appear to interact with
RNA. This functional cluster suggests that disruptions to
some aspect of RNA processing/metabolism can substantially
increase the number of S2 cells that activate expression of the
Dipt-lacZ reporter in response to LPS exposure. While we do
not know how RNA metabolism contributes to this pheno-
type, the repeated independent isolation of genes lying in a
functional cluster reinforces a conclusion that the process is
involved. Several other functional clusters were picked up in
our screens. Three genes involved in Ras signaling (MESR4,
Ras, and Cnk) were identiﬁed as EDRi genes. In addition, we
noted weak EDRi phenotypes with three additional Ras
signaling components (rolled/MAPK, Dsor1, and Pointed).
These ﬁndings argue that Ras signaling downregulates
responses to LPS. This might represent a negative feedback
circuit. However, the ﬁnding that MESR4 also has a CDRi
phenotype suggests that the Ras/MAPK pathway may also
impinge on the maintenance of quiescence.
Several genes involved in cytoskeletal structure or regu-
lation were identiﬁed among the inhibitors. Genes encoding
tubulin (a-Tub84D), a kinesin motor (Klp10A), and micro-
tubule-severing function (CG4448/katanin) were isolated as
EDRi genes. Perhaps an event involving microtubule struc-
tures helps limit immune responses. The two cellular actin
genes (Act5C and Act42A) were individually dispensable, but
their joint inactivation produced both EDRi and CDRi
phenotypes. A regulator of actin function, SCAR, was also
identiﬁed as a CDRi, and both actin and SCAR CDRi
phenotypes fell into epistasis Group II. This suggests that
disruption of the actin cytoskeleton in quiescent cells can
activate the immune response in a Relish-dependent fashion.
Since S2 cells are induced to phagocytose bacteria, and
changes in cell shape are induced in response to LPS, it would
not be surprising if cytoskeletal functions contribute to
Table 3. Measurement of the Percent of LacZ-Positive Cells after







CG1804 I 10.0 9.5
xmas-1 I 8.6 8.1
Plkk1 I 10.2 10.0
SCAR II 12.7 11.7
CG8211 II 8.3 7.4
CG9646 II 8.9 8.6
pUf68 II 10.1 10.7
MESR4 III 10.8 3.9
dnr1 IV 9.1 0.8
Eip93F V 6.7 0.8
Cell culture conditions were as described in the body of the manuscript, with the
exception that cells were not treated with LPS. For each sample, 350–550 cells were
counted.
DOI: 10.1371/journal.pbi0.0020203.t003
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RNAi Screen of Innate ImmunityFigure 4. Dnr1 Is a Conserved Inhibitor of Dredd Activity
(A) A comparison of the amino acid sequence of Dnr1 with XP_32149 from Anopheles gambiae and human MIR. Shaded regions indicate the N-
terminal ezrin/radixin/moesin domain and C-terminal RING ﬁnger. Asterisks indicate conserved residues.
(B) Measurements of b-galactosidase activity in lysates prepared from Dipt-lacZ in control cells, LPS-treated cells, dnr1 dsRNA –treated cells, and
sick dsRNA–treated cells exposed to LPS, respectively. Each experiment was performed in triplicate.
(C) Similarity between the RING ﬁnger in Dnr1 and other IAPs. Critical residues are shaded. Asterisks indicate conserved residues.
(D) Lysates from S2 cells transfected with equal amounts of N- and C-terminally HA-tagged wild-type Dnr1 (lanes 1 and 3, respectively), or N-
and C-terminally HA-tagged C563Y Dnr1 (lanes 2 and 4, respectively), and analyzed by an anti-HA Western blot. Residue C563 is critical for
RING ﬁnger function and is indicated with an arrowhead in (C).
(E) Higher resolution of lysates from C-terminally HA-tagged wild-type or C563Y Dnr1. Mutation of the RING ﬁnger prevents accumulation of a
lower isoform of Dnr1.
(F and G) Subcellular localization of HA-Dnr1 transiently expressed in S2 cells treated without (F) or with (G) LPS, with HA in green, DNA in
blue, and actin in red.
DOI: 10.1371/journal.pbi0.0020203.g004
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RNAi Screen of Innate Immunityimmune responses. Indeed, microarray studies showed
induction of numerous cytoskeletal components in S2 cells
upon incubation with LPS (Boutros et al. 2002). Our ﬁndings,
however, suggest a different involvement of the cytoskeleton
in which it functions to constrain S2 cells, preventing or
limiting their innate immune responses.
A previous conventional genetic screen for mutations
leading to constitutive action of the Imd pathway in
Drosophila larvae demonstrated that Relish basal signaling is
maintained at a low level by proteosomal destruction of
processed Relish (Khush et al. 2002). A Skp1/Cullin/F-box
(SCF) component was identiﬁed as involved in ubiquitination
of the N-terminal Relish domain. We did not include any
genes in the category of ubiquitination and proteasome
function in our CDRi group. This might mean that this
pathway does not inﬂuence the cellular responses in the S2
tissue culture system. However, our ﬁrst round of screening
suggested that RNAi to a Drosophila F-box resulted in
increased basal signaling (unpublished data). This and other
tentative indications of involvement of this pathway were
either not reproduced or fell below the threshold in retesting.
We are left uncertain about SCF contributions to immune
induction in our system.
A GFP-Relish Reporter Line Subdivides DDRi Genes
As in the case of the CDRi and EDRi phenotypes, our
screen for DDRi phenotypes identiﬁed numerous genes
Figure 5. Dnr1 Protein Levels Are Regu-
lated by Dredd Activity
(A) Amounts of HA-Dnr1 transiently
increase in S2 cells treated with LPS.
Anti-HA Western blot of lysates from
HA-Dnr1-transfected S2 cells that were
incubated with LPS for indicated peri-
ods.
(B) Anti-HA Western blot of lysates from
S2 cells transfected with HA-Dnr1. Co-
expression of the caspase inhibitor p35
dramatically inhibits HA-Dnr1 accumu-
lation in the absence (lanes 1 vs. 3) or
presence (lanes 2 vs. 4) of LPS. Actin
levels are shown as a loading control.
(C) Upper panel shows the percentage of
cells with nuclear GFP-Relish after the
indicated treatments. The lower panel is
an anti-GFP Western blot of lysates from
S2 cells treated in the identical manner.
z-VAD-FMK prevents nuclear accumula-
tion of GFP-Relish and GFP-Relish pro-
cessing in response to LPS.
(D) Anti-HA Western blot of lysates from
S2 cells transiently transfected with HA-
Dnr1. While 2 h incubation with LPS
normally leads to a 4-fold increase
(quantiﬁed by titration) in HA-Dnr1
(lanes 1 vs. 2), incubation with z-VAD-
FMK prevents the accumulation (lanes 3
vs. 4).
(E) Anti-HA Western blot of lysates from
S2 cells transfected with HA-Dnr1. Cells
h a db e e np r e v i o u s l yi n c u b a t e dw i t h
(lanes 3 and 4) or without (lanes 1 and
2) Dredd dsRNA. Results are shown for
two independent experiments. Actin
levels are shown as a loading control.
(F) Anti-HA Western Blot of lysates from S2 cells transfected with HA-Dnr1 shows that prior RNAi against the caspases Dcp-1, Ice, Nc, and Decay
does not substantially affect HA-Dnr1 levels (compare with control without LPS).
(G) The number of Dipt-lacZ-expressing cells after LPS treatment is greatly reduced after Dredd RNAi, while RNAi against Dcp-1, Ice, Nc, or
Decay has no effect.
DOI: 10.1371/journal.pbi0.0020203.g005
Figure 6. A Schematic of the Proposed Relationships of the Novel
Immune Regulators, Sick and Dnr1, to Dredd and Rel
Pointed and blunt arrows indicate activation and inhibition,
respectively. Both Sick and Dredd are required for translocation of
Rel to the nucleus and for activation of Dipt expression and they are
consequently positioned upstream of Rel as activators. In the absence
of Sick or Dredd, Dnr1 function is not needed to maintain pathway
quiescence. Thus, Dnr1 is ordinarily required to either inhibit Sick
and Dredd functions or to negate their actions, and we have indicated
these regulators as being downstream of Dnr1 (A). Although we have
no epistatic data that separates the action of Sick and Dredd, Dredd
appears to directly cleave Rel and is hence likely to be immediately
upstream of Rel. Sick might function in conjunction with Dredd or as
an activator of Dredd. Since dnr1 RNAi does not enhance the
response to LPS, we suggest that its inhibitor activity is either
repressed or bypassed upon exposure to LPS. Consequently, we have
shown that treatment with LPS counteracts Dnr1-dependent Dredd
inhibition (B). We do not mean to preclude other actions of LPS that
might contribute to induction, but it is notable that inactivation of
Dnr1 is sufﬁcient to activate signaling. Finally, we have shown that
Dnr1 levels are affected by Dredd, and we have indicated this with a
positive feedback arrow.
DOI: 10.1371/journal.pbi0.0020203.g006
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RNAi Screen of Innate Immunityfalling into functional categories. One potential limitation of
our approach for identiﬁcation of DDRi is that some genes
required for ecdysone maturation may be selected as immune
deﬁcient. Additionally, one of the largest functional catego-
ries was genes involved in translation and included four
ribosomal proteins, three initiation factors, two amino acyl-t-
RNA synthases, and an elongation factor. It seems likely that
RNAi of genes in this category affects translation of the Dipt-
LacZ reporter, as opposed to affecting modulation of signal-
ing events. To cull our collection of DDRis of such indirect
modulators of the response, we developed a secondary screen
that does not rely on de novo gene expression. Based on the
previously described phenotypes of Imd pathway members,
we reasoned that inactivation of the core components
transducing the signal would compromise activation of the
Relish transcription factor. To identify DDRi dsRNAs that
prevented Relish activation, we prepared a GFP-Relish
reporter cell line and rescreened DDRi dsRNAs for loss of
GFP nuclear translocation in response to LPS.
In addition to conﬁrming a requirement for Dredd and
PGRP-LC in Relish activation, we implicated a proteosomal
regulatory subunit Dox-A2 and identiﬁed a novel gene sick as
involved in Relish nuclear translocation in response to LPS.
Although cells treated with sick dsRNA failed to mount an
immune response, the cells were otherwise healthy through
the course of the experiment. Dox-A2 RNAi reduced the
survival of cells and was effectively lethal within a few days of
the scoring of the immune response. We conclude from this
that Sick and Dox-A2 contribute to the central signal
transduction process, but it is presently unclear whether
Dox-A2 has a signiﬁcant speciﬁc input or if its effects are
secondary to a global effect on cell viability.
It is notable that only two DDRi genes passed our
secondary screen based on GFP-Relish localization. Does this
mean that all the other DDRis are not really involved? While
we have not yet analyzed all these genes, we suspect that many
of them will modify the Imd pathway, either impinging on the
pathway at a point beyond Relish translocation, or quantita-
tively or kinetically modifying Relish translocation in a
manner that we did not detect in our screens. Insight into
this issue is likely to be derived from further epistasis tests
that might place some of these DDRis in the signaling
pathway.
An Epistatic Network to Position CDRi and DDRi Genes
We identiﬁed an unprecedented large number of immune
response inhibitors (CDRi genes) in our screens. As there are
diverse steps within and potentially outside the Imd signaling
pathway at which the CDRi inhibitors might act, we sought to
position their actions with respect to known Imd pathway
functions by RNAi epistasis tests. By sequential inactivation
of known Imd pathway components and CDRi gene products,
we tested whether constitutive activation of immune report-
ers by CDRi dsRNAs depends on steps in the signal
transduction pathway. In this way, we deﬁned ﬁve distinct
epistatic categories of CDRi gene products. The four CDRi
genes that continue to activate immune responses despite
inactivation of Imd, Dredd, or Relish are likely to act on
signal-transduction-independent factors that maintain tran-
scriptional quiescence of Dipt. The largest group of CDRis
(12) depends on Relish function but not on upstream
activators of Relish. These are likely to include two types of
regulators: one type that sets the threshold of response so that
basal activity of Relish does not trigger pathway activity, and a
second type that contributes to suppression of Relish activity.
The latter type of regulator might include inhibitors that
impinge on the late steps in the signal transduction cascade.
For example, genes whose normal function inhibits the
activity of the full-length Relish transcription factor might
be required to make the pathway activator dependent, and
these would be found in this category. The remaining
upstream epistasis groups that rely on additional signal
transduction components are strongly implicated as signiﬁ-
cant contributors to the immune induction pathway. As all of
the CDRis induced robust immune responses in the absence
of ecdysone (unpublished data), we propose that the CDRis
have their input into the Imd pathway at a level that is the
same or lower than the level of the input from ecdysone.
Given that this is true for all ﬁve epistatic groups of CDRis,
the result suggests that ecdysone has its input at an early level
of the Imd pathway.
The identiﬁcation of ﬁve epistasis groups of inhibitors also
provides reference points for a second round of epistasis tests
that position novel DDRi genes within the Imd pathway. We
used this approach to show that the novel DDRi sick is
required for constitutive activation of the responses by
inactivation of CDRi genes in Groups III, IV, and V genes
but not for the action of CDRi Group II or Group I genes. If
we assume a simple linear pathway, this would indicate that
Sick functions upstream of Relish and downstream of Imd
and Dredd. It is noteworthy that the epistatic data are
consistent with molecular data indicating that Sick is
required for Dipt-lacZ induction and the nuclear trans-
location of Relish in response to LPS. This combination of
phenotypic, epistatic, and molecular data argues for partic-
ipation of Sick in the regulated activation of the Relish
transcription factor.
Dnr1 Prevents Ectopic Dredd-Dependent Relish Activation
One epistatic group struck us as particularly interesting.
While Dnr1 inactivation caused ectopic Dipt-lacZ expression,
simultaneous loss of Dredd or Relish restored cells to their
resting state. These data indicate that the wild-type function
of Dnr1 is to prevent Dredd-dependent activation of Relish.
Consistent with this hypothesis, we identiﬁed a C-terminal
RING ﬁnger in Dnr1 with greatest similarity to the RING
ﬁnger motifs observed in the C-terminus of IAP proteins. In
addition to regulating caspase activity, IAPs also regulate
their own stability through ubiquitin-mediated proteolysis.
Similarly, we observed that mutation of a critical RING ﬁnger
residue greatly stabilized Dnr1. These features suggest that
Dnr1 is a caspase inhibitor, suggesting that it might act
directly to inhibit Dredd activity.
We observed that exposure of cells to LPS transiently
stabilized Dnr1 and that this stabilization directly paralleled
the period of Dredd-dependent Relish processing. This
suggested to us that Dnr1 stability and accumulation might
be regulated by its target, Dredd, a regulatory connection that
could establish a negative feedback loop. We conﬁrmed that
Dredd activity is required for accumulation of Dnr1. These
results suggest that Dredd modulates a RING-ﬁnger-depen-
dent Dnr1 destruction pathway (Figure 6).
Our results are consistent with a feedback inhibitory loop
where Dredd activity promotes accumulation of its own
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RNAi Screen of Innate Immunityinhibitor (Figure 6); however, it is not clear under what
circumstance this loop functions. Since Dnr1 inactivation did
not enhance Dipt-lacZ production by LPS, we propose that
Dnr1 inhibition of Dredd is suppressed or bypassed by LPS
treatment and that Dnr1 is not essential for downregulation
of an ongoing response. Further, as suppression of Dnr1 by
RNAi is sufﬁcient to activate immune responses, Dnr1
functions in the absence of induction and this function is
required for quiescence. Thus, LPS inactivation of Dnr1
function ought to be sufﬁcient to trigger Dredd-dependent
cleavage of Relish in the Imd pathway, and it could make a
signiﬁcant contribution to pathway activation.
In summary, a new and powerful screening approach has
provided many candidate regulators of the Imd pathway of
the innate immune response, and we suggest that the newly
identiﬁed contributors Dnr1 and Sick will govern central
steps in the regulatory cascade that activates the Relish
transcription factor. While our analysis has led to a focus on
these two regulators, we suspect that other genes among those
isolated will also make important direct contributions to the
Imd pathway. Furthermore, some of the groups of genes
falling into functional clusters are likely to deﬁne physiolog-
ically relevant inputs into the induction pathway.
Materials and Methods
Generation of dsRNA library. A library of DNA templates bearing
the T7 RNA polymerase promoter at each 59 end was prepared from
genomic DNA in a two-step PCR protocol. In the ﬁrst round of PCR,
targeted regions of DNA were ampliﬁed using gene-speciﬁc primers
(18–22 nucleotides) with a 59 GC-rich anchor (GGGCGGGT). Primers
were designed to amplify a region of nonintronic genomic DNA
between 250 and 800 bp with minimal sequence overlap to all other
amplimers. Templates from the ﬁrst step were ampliﬁed in a second
round using a universal primer containing the T7 RNA polymerase
promoter sequence followed by the GC-rich anchor TAATACGACT-
CACTATAGGGAGACCACGGGCGGGT. dsRNA was generated from
templates in in-vitro transcription reactions for 6 h at 37 8C. In vitro
transcription products were annealed by heating to 65 8C and slowly
cooling to room temperature. All products were tested for yield and
size by gel electrophoresis, with 97% giving satisfactory results.
Generation of stable cell lines. Dipt-lacZ cell and copper-inducible
GFP-Relish stable S2 cell lines were generated according to the
Invitrogen Drosophila Expression System Protocol using hygromycin B
(Invitrogen, Carlsbad, California, United States) as a selection marker.
The Dipt-lacZ plasmid has been described previously (Dimarcq et al.
1997). To prepare N-terminally GFP-tagged full-length Relish, the
stop codon in enhanced GFP (EGFP) was replaced with a Not site, and
EGFP was cloned into pUAST as an EcoRI/NotI fragment. Full-length
Relish cDNA was fused in frame to the EGFP coding sequence as a
NotI/XbaI fragment, and the entire sequence was conﬁrmed by
sequencing. GFP-Relish was cloned into pMT/V5-HisB as an EcoRI/
XbaI fragment to allow copper-inducible expression of GFP-Relish
under control of the metallothionine promoter.
Cell culture. S2 cells were plated into glass-bottomed 96-well
microplates (BD Biosciences Pharmingen, San Diego, California,
United States) with 40,000–50,000 cells in 200 ll of Schneider’s
Drosophila medium (GIBCO, San Diego, California, United States)
supplemented with 10% heat-inactivated fetal calf serum, penicillin,
streptomycin, and hygromycin per well. dsRNA was added to each
well at a ﬁnal concentration of 10 lg/ml. Cells were cultured for 4 d at
25 8C and incubated an additional 24 h in 1 lM 20-hydroxyecdysone
(Sigma, St. Louis, Missouri, United States). LPS (Calbiochem, San
Diego, California, United States) was added at a ﬁnal concentration of
50 lg/ml for 12 h. RNAi protocols were as previously described
(Clemens et al. 2000).
b-galactosidase assays. To measure b-galactosidase in S2 cells,
medium was aspirated from the wells, and cells were ﬁxed in 0.5%
glutaraldehyde in PBS for 30 s. Cells were then incubated in X-Gal
staining buffer overnight at 37 8C (10 mM phosphate buffer [pH 7.2],
150 mM NaCl, 1 mM MgCl2, 3.5 mM K3Fe(CN)6, 3.5 mM K4Fe(CN)6,
and 0.2% X-Gal in DMF). b-galactosidase activity assays were
performed as described previously (Dimarcq et al. 1997).
Microscopy, immunoﬂuorescence, and image processing. b-galac-
tosidase induction in S2 cells was observed with a Leica (Wetzlar,
Germany) IMRB microscope. Immunoﬂuorescent images were taken
on an Olympus (Tokyo, Japan) IX70 driven with DeltaVision software
(Applied Precision, Issaquah, Washington, United States). S2 cells
were deposited on Superfrost Plus Gold slides (Fisher Scientiﬁc,
Hampton, New Hampshire, United States) for immunoﬂuorescence.
Cells were ﬁxed for 10 min in 4% formaldehyde (Sigma). Tubulin was
detected with mouse anti-a-tubulin (Sigma). DNA was visualized with
Hoechst 33258, and actin was visualized with rhodamine-coupled
phalloidin (both from Molecular Probes, Eugene, Oregon, United
States). Images were processed with Adobe Photoshop 5.5, and ﬁgures
were assembled with Adobe Illustrator 9.0.
Western blotting. Dnr1-expressing vectors were prepared by
cloning Dnr1 cDNA into pAc5/V5HisA (Invitrogen). The C365Y
mutant form of Dnr1 was prepared with the Stratagene point
mutation protocol using a TTCAATCCGTACTGTCACGTC sense
primer and a GACGTGACAGTACGGATTGAA antisense primer.
The mutation was conﬁrmed by sequencing. For experiments with z-
VAD-FMK, S2 cells were incubated in 100 lM z-VAD-FMK for 4 h at
room temperature. Cells were harvested by centrifugation at 1,000 g
for 3 min, washed in PBS and lysed on ice for 10 min in lysis buffer
(0.5 M HEPES [pH 7.5], 150 mM NaCl, 5 mM EDTA, 0.2% NP40,
PMSF, leupeptin, pepstatin, NaF, and microcystine LR). Lysate was
spun for 10 min at maximum speed, and the supernatant was added
to sample loading buffer. Samples were separated by SDS-PAGE and
analyzed by Western blotting. Anti-GFP antibody was purchased from
BabCO (Richmond, California, United States), and HA and actin
antibodies were purchased from Sigma.
Acknowledgments
The dsRNA library used in this screen was produced in collaboration
with Ben Eaton, Nico Stuurman, Steve Rogers, Graeme Davis, and
Ron Vale at the University of California, San Francisco. Dipt-lacZ,
Relish, and p35 DNA plasmids were provided by Jean-Luc Imler, Dan
Hultmark, and Pascal Meijer, respectively. We are grateful to Pascale
Dijkers, Ben Eaton, Arnaud Echard, Gilles Hickson, Sandy Johnson,
Bruno Lemaitre, Maria Carla Saleh, and Shannon Stroschein for
comments on the manuscript. This work was supported by a gift from
the Sandler Family, and National Instititutes of Health Research
Grant GM 60988 to PHO. Supported in part by Fellowship DRG-
1713–02 from the Damon Runyon Cancer Research Foundation.
Conﬂicts of interest. The authors have declared that no conﬂicts of
interest exist.
Author contributions. EF and PHO’F conceived and designed the
experiments. EF performed the experiments. EF and PHO’F analyzed
the data and wrote the paper. &
References
Akira S, Takeda K, Kaisho T (2001) Toll-like receptors: Critical proteins linking
innate and acquired immunity. Nat Immunol 2: 675–680.
Anderson KV, Jurgens G, Nusslein-Volhard C (1985) Establishment of dorsal-
ventral polarity in the Drosophila embryo: Genetic studies on the role of the
Toll gene product. Cell 42: 779–789.
Bergmann A, Yang AY, Srivastava M (2003) Regulators of IAP function: Coming
to grips with the grim reaper. Curr Opin Cell Biol 15: 717–724.
Boutros M, Agaisse H, Perrimon N. (2002) Sequential activation of signaling
pathways during innate immune responses in Drosophila. Dev Cell 3: 711–
722.
Choe KM, Werner T, Stoven S, Hultmark D, Anderson KV (2002) Requirement
for a peptidoglycan recognition protein (PGRP) in Relish activation and
antibacterial immune responses in Drosophila. Science 296: 359–362.
Clemens JC, Worby CA, Simonson-Leff N, Muda M, Maehama T, et al. (2000)
Use of double-stranded RNA interference in Drosophila cell lines to dissect
signal transduction pathways. Proc Natl Acad Sci U S A 97: 6499–6503.
De Gregorio E, Spellman PT, Tzou P, Rubin GM, Lemaitre B (2002) The Toll
and Imd pathways are the major regulators of the immune response in
Drosophila. EMBO J 21: 2568–2579.
Dimarcq JL, Imler JL, Lanot R, Ezekowitz RA, Hoffmann JA, et al. (1997)
Treatment of 1(2)mbn Drosophila tumorous blood cells with the steroid
hormone ecdysone ampliﬁes the inducibility of antimicrobial peptide gene
expression. Insect Biochem Mol Biol 27: 877–886.
PLoS Biology | www.plosbiology.org August 2004 | Volume 2 | Issue 8 | e203 1105
RNAi Screen of Innate ImmunityDrier EA, Huang LH, Steward R (1999) Nuclear import of the Drosophila Rel
protein Dorsal is regulated by phosphorylation. Genes Dev 13: 556–568.
Dushay MS, Asling B, Hultmark D (1996) Origins of immunity: Relish, a
compound Rel-like gene in the antibacterial defense of Drosophila. Proc Natl
Acad Sci U S A 93: 10343–10347.
Engstrom Y, Kadalayil L, Sun SC, Samakovlis C, Hultmark D, et al. (1993) Kappa
B-like motifs regulate the induction of immune genes in Drosophila. J Mol
Biol 232: 327–333.
Foley E, O’Farrell PH (2003) Nitric oxide contributes to induction of innate
immune responses to gram-negative bacteria in Drosophila. Genes Dev 17:
115–125.
Georgel P, Naitza S, Kappler C, Ferrandon D, Zachary D, et al. (2001) Drosophila
immune deﬁciency (IMD) is a death domain protein that activates
antibacterial defense and can promote apoptosis. Dev Cell 1: 503–514.
Gobert V, Gottar M, Matskevich AA, Rutschmann S, Royet J, et al. (2003) Dual
activation of the Drosophila toll pathway by two pattern recognition
receptors. Science 302: 2126–2130.
Gottar M, Gobert V, Michel T, Belvin M, Duyk G, et al. (2002) The Drosophila
immune response against gram-negative bacteria is mediated by a
peptidoglycan recognition protein. Nature 416: 640–644.
Hedengren M, Asling B, Dushay MS, Ando I, Ekengren S, et al. (1999) Relish, a
central factor in the control of humoral but not cellular immunity in
Drosophila. Mol Cell 4: 827–837.
Hoffmann JA (2003) The immune response of Drosophila. Nature 426: 33–38.
Hoffmann JA, Kafatos FC, Janeway CA, Ezekowitz RA (1999) Phylogenetic
perspectives in innate immunity. Science 284: 1313–1318.
Horng T, Medzhitov R (2001) Drosophila MyD88 is an adapter in the Toll
signaling pathway. Proc Natl Acad Sci U S A 98: 12654–12658.
Hu S, Yang X (2000) dFADD, a novel death domain-containing adapter protein
for the Drosophila caspase DREDD. J Biol Chem 275: 30761–30764.
Ip YT, Reach M, Engstrom Y, Kadalayil L, Cai H, et al. (1993) Dif, a dorsal-
related gene that mediates an immune response in Drosophila. Cell 75: 753–
763.
Janeway CA Jr, Medzhitov R (2002) Innate immune recognition. Annu Rev
Immunol 20: 197–216.
Khush RS, Cornwell WD, Uram JN, Lemaitre B (2002) A ubiquitin-proteasome
pathway represses the Drosophila immune deﬁciency signaling cascade. Curr
Biol 12: 1728–1737.
Kurz CL, Ewbank JJ (2003) Caenorhabditis elegans: An emerging genetic model for
the study of innate immunity. Nat Rev Genet 4: 380–390.
Lemaitre B, Kromer-Metzger E, Michaut L, Nicolas E, Meister M, et al. (1995) A
recessive mutation, immune deﬁciency (imd), deﬁnes two distinct control
pathways in the Drosophila host defense. Proc Natl Acad Sci U S A 92: 9465–
9469.
Lemaitre B, Nicolas E, Michaut L, Reichhart JM, Hoffmann JA (1996) The
dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent
antifungal response in Drosophila adults. Cell 86: 973–983.
Leulier F, Rodriguez A, Khush RS, Abrams JM, Lemaitre B (2000) The Drosophila
caspase Dredd is required to resist gram-negative bacterial infection. EMBO
Rep 1: 353–358.
Leulier F, Vidal S, Saigo K, Ueda R, Lemaitre B (2002) Inducible expression of
double-stranded RNA reveals a role for dFADD in the regulation of the
antibacterial response in Drosophila adults. Curr Biol 12: 996–1000.
Li X, Scuderi A, Letsou A, Virshup DM (2002) B56-associated protein
phosphatase 2A is required for survival and protects from apoptosis in
Drosophila melanogaster. Mol Cell Biol 22: 3674–3684.
Ligoxygakis P, Pelte N, Hoffmann JA, Reichhart JM (2002) Activation of
Drosophila Toll during fungal infection by a blood serine protease. Science
297: 114–116.
Lu Y, Wu LP, Anderson KV (2001) The antibacterial arm of the Drosophila
innate immune response requires an IkappaB kinase. Genes Dev 15: 104–
110.
Manfruelli P, Reichhart JM, Steward R, Hoffmann JA, Lemaitre B (1999) A
mosaic analysis in Drosophila fat body cells of the control of antimicrobial
peptide genes by the Rel proteins Dorsal and DIF. EMBO J 18: 3380–3391.
Medzhitov R, Janeway C Jr (2000) Innate immunity. N Engl J Med 343: 338–344.
Meng X, Khanuja BS, Ip YT (1999) Toll receptor-mediated Drosophila immune
response requires Dif, an NF-kappaB factor. Genes Dev 13: 792–797.
Michel T, Reichhart JM, Hoffmann JA, Royet J (2001) Drosophila Toll is activated
by gram-positive bacteria through a circulating peptidoglycan recognition
protein. Nature 414: 756–759.
Naitza S, Rosse C, Kappler C, Georgel P, Belvin M, et al. (2002) The Drosophila
immune defense against gram-negative infection requires the death protein
dFADD. Immunity 17: 575–581.
Nicolas E, Reichhart JM, Hoffmann JA, Lemaitre B (1998) In vivo regulation of
the IkappaB homologue cactus during the immune response of Drosophila.J
Biol Chem 273 10463–10469.
Ramet M, Manfruelli P, Pearson A, Mathey-Prevot B, Ezekowitz RA (2002)
Functional genomic analysis of phagocytosis and identiﬁcation of a
Drosophila receptor for E. coli. Nature 416: 644–648.
Rosetto M, Engstrom Y, Baldari CT, Telford JL, Hultmark D (1995) Signals from
the IL-1 receptor homolog, Toll, can activate an immune response in a
Drosophila hemocyte cell line. Biochem Biophys Res Commun 209: 111–116.
Rutschmann S, Jung AC, Hetru C, Reichhart JM, Hoffmann JA, et al. (2000a).
The Rel protein DIF mediates the antifungal but not the antibacterial host
defense in Drosophila. Immunity 12: 569–580.
Rutschmann S, Jung AC, Zhou R, Silverman N, Hoffmann JA, et al. (2000b).
Role of Drosophila IKK gamma in a toll-independent antibacterial immune
response. Nat Immunol 1: 342–347.
Rutschmann S, Kilinc A, Ferrandon D (2002) Cutting edge: The toll pathway is
required for resistance to gram-positive bacterial infections in Drosophila.J
Immunol 168: 1542–1546.
Ryu JH, Nam KB, Oh CT, Nam HJ, Kim SH, et al. (2004) The homeobox gene
Caudal regulates constitutive local expression of antimicrobial peptide
genes in Drosophila epithelia. Mol Cell Biol 24: 172–185.
Samakovlis C, Asling B, Boman HG, Gateff E, Hultmark D (1992) In vitro
induction of cecropin genes—An immune response in a Drosophila blood cell
line. Biochem Biophys Res Commun 188: 1169–1175.
Schmid A, Schindelholz B, Zinn K (2002) Combinatorial RNAi: A method for
evaluating the functions of gene families in Drosophila. Trends Neurosci 25:
71–74.
Silverman N, Zhou R, Stoven S, Pandey N, Hultmark D, et al. (2000) A Drosophila
IkappaB kinase complex required for Relish cleavage and antibacterial
immunity. Genes Dev 14: 2461–2471.
Silverman N, Zhou R, Erlich RL, Hunter M, Bernstein E, et al. (2003) Immune
activation of NF-kappaB and JNK requires Drosophila TAK1. J Biol Chem
278: 48928–48934.
Stoven S, Ando I, Kadalayil L, Engstrom Y, Hultmark D (2000) Activation of the
Drosophila NF-kappaB factor Relish by rapid endoproteolytic cleavage.
EMBO Rep 1: 347–352.
Stoven S, Silverman N, Junell A, Hedengren-Olcott M, Erturk D, et al. (2003)
Caspase-mediated processing of the Drosophila NF-kappaB factor Relish.
Proc Natl Acad Sci U S A 100: 5991–5996.
Tauszig S, Jouanguy E, Hoffmann JA, Imler JL (2000) Toll-related receptors and
the control of antimicrobial peptide expression in Drosophila. Proc Natl
Acad Sci U S A 97: 10520–10525.
Tauszig-Delamasure S, Bilak H, Capovilla M, Hoffmann JA, Imler JL (2002)
Drosophila MyD88 is required for the response to fungal and gram-positive
bacterial infections. Nat Immunol 3: 91–97.
Vidal S, Khush RS, Leulier F, Tzou P, Nakamura M, et al. (2001) Mutations in
the Drosophila dTAK1 gene reveal a conserved function for MAPKKKs in the
control of rel/NF-kappaB-dependent innate immune responses. Genes Dev
15: 1900–1912.
Weber AN, Tauszig-Delamasure S, Hoffmann JA, Lelievre E, Gascan H, et al.
(2003) Binding of the Drosophila cytokine Spatzle to Toll is direct and
establishes signaling. Nat Immunol 4: 794–800.
Wu LP, Anderson KV (1998) Regulated nuclear import of Rel proteins in the
Drosophila immune response. Nature 392: 93–97.
Yang Y, Fang S, Jensen JP, Weissman AM, Ashwell JD (2000) Ubiquitin protein
ligase activity of IAPs and their degradation in proteasomes in response to
apoptotic stimuli. Science 288: 874–877.
PLoS Biology | www.plosbiology.org August 2004 | Volume 2 | Issue 8 | e203 1106
RNAi Screen of Innate Immunity